Historical Evidence Density and Hazard Classification of UV-Curable (Meth)acrylate Monomers

Historical UV printing provides an unusually clear natural experiment in chemical evidence generation. Beginning in the 1970s, dermatitis investigations repeatedly identified multifunctional acrylates including TMPTA, PETA, HDDA and later TPGDA in workers exposed to UV-curing inks and coatings [1-7]. A large UK study subsequently used Graphical, Paper and Media Union membership to quantify skin complaints across printing activities, while current UK HSE guidance continues to identify UV-cured ink use as a printing activity with elevated skin-risk concern [8,15]. These records do not establish a simple intrinsic-hazard ranking between monomers. They show that commercial prevalence, contact opportunity, diagnostic attention, analytical availability and regulatory follow-up determine how much evidence accumulates around a substance. ECHA's C&L Inventory notification scheme requires a notifier to record whether “no classification” reflects a lack of data, inconclusive data, or data conclusive for non-classification; absence of classification therefore cannot by itself be read as absence of hazard [14]. Independent occupational studies also show that SDS can omit clinically relevant sensitizers [11,12]. ER-91 therefore proposes a four-layer interpretation model separating intrinsic hazard, exposure opportunity, evidence density and regulatory/SDS expression. The framework is intended for UV-curable formulations and VPP, where engineers often compare candidate monomers by SDS severity alone. Such comparison is not scientifically valid unless evidence density, purity, exposure route and test history are also considered.